Cite
MLA Citation
Yoland Antill et al.. “Clinical activity of durvalumab for patients with advanced mismatch repair-deficient and repair-proficient endometrial cancer. A nonrandomized phase 2 clinical trial.” Journal for immunotherapy of cancer, vol. 9, no. 6, 2021, p. . http://access.bl.uk/ark:/81055/vdc_100132247189.0x000031